Using death to one's advantage: HIV modulation of apoptosis

Leukemia

Volumn 15, Issue 3, 2001, Pages 332-341

  Ross, T M ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

AIDS; Apoptosis; HIV; T cell depletion

Indexed keywords

APOPTOSIS INDUCING FACTOR; CD4 ANTIGEN; CD8 ANTIGEN; CELL SURFACE RECEPTOR; INHIBITOR OF APOPTOSIS PROTEIN; NEF PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VPR PROTEIN; VPU PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN PRESENTING CELL; APOPTOSIS; CELL DEATH; CELL DESTRUCTION; CHRONIC DISEASE; DISEASE COURSE; DOWN REGULATION; EFFECTOR CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHESIS; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOMODULATION; LYMPHOCYTE; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; OPPORTUNISTIC INFECTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; VIRUS REPLICATION;

EID: 0035085350     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402028     Document Type: Review

References (153)

1. HIV infection does not require endocytosis of its receptor, CD4
2. Role of chemokine receptors in HIV-1 infection and pathogenesis
3. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
4. Identification of a major co-receptor for primary isolates of HIV-1
5. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
6. CC CKR5: A RANTES, MIP-1a, MIP-1b receptor as a fusion cofactor for macrophage-tropic HIV-1
7. CC Chemokine receptor 5-mediated signaling and HIV-1 co-receptor activity share common structural determinants
8. T cell depletion in HIV-1 infection: How CD4+ T cells go out of stock
9. Fas ligand mediates activation-induced cell death in human T lymphocytes
10. Cell autonomous Fas/Fas ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
11. Autocrine T-cell suicide mediated by APO-1 (Fas/CD95)
12. Fas/FasL interactions required for programmed cell death after T-cell activation
13. Fas-mediated apoptosis of CD4+ and CD8+ T cells from HIV-1 infected persons: Differential in vitro preventive effect of cytokines and protease antagonists
14. Activation of the CD95 (APO-1/Fas) system in T cells from HIV-1 infected children
15. Fas ligand deficiency in HIV disease
16. The Fas receptor in HIV infection: Expression of peripheral blood lymphocytes and role in the depletion of T cells
17. Upregulation of Fas ligand expression by HIV in human macrophages mediates apoptosis of uninfected T lymphocytes
18. Interleukin-1B converting enzyme-like protease involvement in Fas-induced and activation indiced peripheral blood T cell aopotosis in HIV-1 infection. TNF-related apoptosis-inducing ligand can mediate in HIV-1 infection
19. Activation-induced poeripheral blood T cell apoptosis is Fas independent in HIV-1 infected individuals
20. Setting death in motion
21. Apoptosis as a mechanism of cell death in culture T lymphoblasts acutely infected with HIV-1
22. Mapping of HIV-1 determinants of apoptosis in infected T cells
23. The cytopathic effect of HIV is associated with apoptosis
24. Cell dysfunction and depletion in AIDS: The programmed cell death hypothesis
25. The apoptosis endonuclease and its regulation
26. The role of the caspase family of cysteine proteases in apoptosis
27. The cutting edge: Caspases in apoptosis and disease
28. Proteases to die for
29. Mechanisms controlling cellular suicide: Role of Bcl-2 and caspases
30. Structure and mechanisms of inteluekin-1b converting enzyme
31. A preaspartate specific protease from human leukocytes that cleaves pro-interleukin-1b
32. Murine caspase-11, and ICE-interacting protease, is essential for the activation of ICE
33. Human ICE/CED-3 protease nomenclature
34. Calcium-activated neutral protease (calpain) system: Structure, function, and regulation
35. Regulation of apoptosis by viral gene products
36. Cytotoxic T cell derived granzyme B activate the apoptosis protease ICE-LAP3
37. Activation of the apoptotic protease CPP32 by cytotoxic T-cell derived granzyme B
38. Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B
39. A sticky business. Apoptosis
40. Bcl-2 family proteins: The role of the BH3 domain in apoptosis
41. Elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2 like protein CED-9
42. The Bcl-2 protein family; arbiters of cell survival
43. Structure-function analysis of Bcl-2 family protein: Regulators of programmed cell death
44. C. elegans cell survival gene ced-9 encodes a functional homologue of the mammalian proto-oncogene bcl-2
45. Caspase-9, Bcl-x, and Apaf-1 form a ternary complex
46. Bcl-SL interacts with Apaf-1 and inhibits Apaf-1 dependent caspase-9 activation
47. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the inteleukin-1b-convertng enzyme
48. Control of programmed cell death by the baculovirus genes p35 and lap
49. Apoptotic suppression by baculovirus p35 involves cleavage by and inhibition of a virus-induced CED-3/ICE-like protease
50. Inhibition of the Caenorhabditis elegans cell death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein
51. A major human immunodeficiency virus type 1-initiated killing pathway distinct from apoptosis
52. bcl-2 expression facilitates human immunodeficiency virus type-1 mediated cytopathic effects during acute spreading infections
53. Apoptosis occurs predominately in bystander cells and not unproductively infected cells on HIV and SIV-infected lymphocytes
54. Programmed cell death of T cells in human immunodeficiency virus infection, no correlation with progression to disease
55. Tat and the HIV-1 promoter
56. Human immunodeficiency virus as a prototypic complex retrovirus
57. Interferon α and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS
58. Release, uptake, and effects of extracellular HIV-1 Tat protein on cell growth and viral transactivation
59. HIV tat induces functional unresponsiveness in T cells
60. HIV-1 tat potentiates TNF-induced NF-kB activation and cytotoxicity by altering the cellular redox state
61. Inhibition of antigen-specific lymphocyte proliferation by tat protein of HIV-1
62. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein
63. HIV-1 tat protein induces apoptosis and death in Jurkat T-cells
64. Rapid turnover of plasma visions and CD4 lymphocytes in HIV-1 infection
65. HIV-1 Tat binds to dipeptidyl aminopeptidase IV (CD26): A possible mechanism for Tat's immunosuppressive activity
66. Expression of HIV-1 tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells
67. Exogenous HIV-1 Tat protein selectively stimulates a phosphoinositide-specific phospholipase C nuclear pathway in the Jurkat T cell line
68. CD26 mediates the action of HIV-1 Tat protein on DNA synthesis and cytokine production in U937 cells
69. Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein
70. A naturally unbalanced combat
71. Decreased ability of HIV-1 Tat protein-treated accessory cells to organize cellular clusters is associated with partial activation of T cells
72. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine
73. Vaccination with Rev and Tat against AIDS
74. Immunodeficiency virus vaccine: Neutralizing antibody-independent containment of serial challenges by subunit immunization
75. Related evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain
76. Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef
77. Protective immunity of gene-deleted SHIVs having an HIV-1 Env against challenge infection with a gene-intact SHIV
78. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine
79. Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production
80. Protection by live, attenuated simian immuno-deficiency virus against heterologous challenge
81. Properties of virus-like particles produced by SIV-chronically infected human cell clones
82. HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells
83. Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge
84. Identification of HIV-1 Vpr product and function
85. Mutational analysis of the human immunodeficiency virus vpr open reading frame
86. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: Mutational analysis of a primary HIV-1 isolate
87. A leucine triplet repeat sequence (LXX)4 in p6gag is important for vpr incorporation into human immunodeficiency virus type 1 particles
88. In vitro and in vivo tumor growth suppression by HIV-1 Vpr
89. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: Role of a predicted N-terminal alpha-helical structure in vpr nuclear localization and virion incorporation
90. Incorporation of Vpr into human immunodeficiency virus type I virions: Requirement for the p6 region of gag and mutational analysis
91. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection
92. HIV-1 infection of nondividing cells throughout the recognition of integrase by the importin/karyopherin pathway
93. Mutational analysis of cell cycle arrest, nuclear localization, and virion packaging of human immunodeficiency virus type 1 Vpr
94. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells
95. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat
96. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
97. The human immunodeficiency virus type 1 Vpr transactivator: Cooperation with promoter-bound activator domains and binding to TFIIB
98. Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology
99. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B
100. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity
101. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control
102. The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages
103. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest
104. The human immunodeficiency virus type 1 vpr gene arrests infected T-cells in the G2+M phase of the cell cycle
105. Induction of cell differentiation by human immunodeficiency virus 1 vpr
106. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection
107. The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate
108. Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest
109. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme
110. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells
111. Apoptosis. Phagocytic docking without shocking
112. + T cells: Role of signal transduction
113. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4
114. Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes
115. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4
116. CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis
117. Induction of apoptosis in mature T cells by tumour necrosis factor
118. Correlates of apoptosis of CD4+ and CD8+ T cells in tonsillar tissue in HIV type 1 infection
119. Induction of phosphorylation and intracellular association of CC chemokine receptor 5 and focal adhesion kinase in primary human CD4+ T cells by macrophage-tropic HIV envelope
120. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T-lymphocytes
121. Interactions between HIV-1 Nef and vascular ATPase facilitate the internalization of CD4
122. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner
123. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein
124. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proxmial CD4 cytoplasmic domain
125. A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation
126. Identification of regions in HIV-1 Nef required for efficient downregulation of cell surface CD4
127. Serine phosphorylation-independent downregulation of cell-surface CD4 by Nef
128. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 LTR and on cell growth in macrophages
129. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization
130. HIV-1 Nef binding protein expressed on the surface of murine blood cells
131. Induction of Fas ligand expression by HIV involves the interaction of Nef with T cell receptor z chain
132. Induction of fas ligand expression by an acutely lethal simian immunodeficiency virus, SIVsmmPBj14
133. Physical and functional interaction of Nef with Ick-HIV-1 Nef-induced T-cell signaling defects
134. Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines
135. Human immunodeficiency virus type 1 Nef associates with cellular serine kinase in T lymphocytes
136. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A
137. Binding of c-Raf1 kinase to a conserved acidic sequence within the carboxyl-terminal region of the HIV-1 Nef protein
138. Rho GTPases and signaling networks
139. A novel human WD protein, hBrCP, that interact with HIV-1 Vpu connects CD4 to the ER degradation pathway throughout an F-box motif
140. The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses
141. A novel gene of HIV-1 vpu, and its 16 kilodalton product
142. The Vpu protein of human immunodeficiency virus type 1 forms ion cation-selective ion channels
143. Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1 infected cells
144. A primary role for K+ and Na+ efflux in the activation of apoptosis
145. A DEVD-inhibited caspase other than CPP32 is involved in the commitment of cerebellar granule neurons to apoptosis induced by K+ deprivation
146. Tyrosine phosphorylation-dependent suppression of a voltage-gated K+ channel in T-lymphocytes upon Fas stimulation
147. Bcl-XL forms an ion channel in synthetic lipid membranes
148. Channel formation by antiapoptotic protein Bcl-2
149. Inhibition of Bax channel-forming activity by Bcl-2
150. A cell-free stock of simian-human immunodeficiency virus that causes AIDS in pig-tailed macaques has limited number of amino acid substitutions in both SIVmac and HIV-1 regions of the genome and has altered cytotropism